Skip to content
Wenlo
Sign in
← Markets

Insmed Incorporated

Orlov S Nicole Schaeffer (Chief People Strategy Officer) sells INSM shares

4INSMFiled Nov 20, 2026, 4:33 PM ET· Period Nov 19, 2026

AI-generated summary

Chief People Strategy Officer Orlov S Nicole Schaeffer exercised 101,100 shares for $2,895,335 and sold 101,100 shares for $14,685,601.58 directly on November 19, 2026. After these transactions, the insider directly held 41,895 shares of Common Stock. The transactions were executed under a Rule 10b5-1 trading plan adopted on May 11, 2026.

Key facts

Insider
Orlov S Nicole Schaeffer · Chief People Strategy Officer

Rule 10b5-1 plan · adopted May 11, 2026

DateTransactionSharesPriceValueHeld afterOwnership
Nov 19, 2026M · exercise or conversion of a derivativeFootnotes F1, F2+55,400$30.46$1,687,484.0097,295Direct
Nov 19, 2026M · exercise or conversion of a derivativeFootnotes F1+45,700$26.43$1,207,851.00142,995Direct
Nov 19, 2026S · open-market saleFootnotes F1, F3−90,299$145.06$13,098,772.9452,696Direct
Nov 19, 2026S · open-market saleFootnotes F1, F4−8,539$146.76$1,253,183.6444,157Direct
Nov 19, 2026S · open-market saleFootnotes F1, F5−2,262$147.50$333,645.0041,895Direct
Nov 19, 2026M · exercise or conversion of a derivativeStock Option (right to buy)Footnotes F1, F6−55,400$0.00$0.000Direct
Nov 19, 2026M · exercise or conversion of a derivativeStock Option (right to buy)Footnotes F1, F6−45,700$0.00$0.000Direct
Footnotes
  1. F1 This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on May 11, 2026, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
  2. F2 Includes 141 shares acquired through the Company's 2018 Employee Stock Purchase Plan.
  3. F3 This is the weighted average sales price representing 90,299 shares sold at prices ranging from $145.00 to $145.93 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  4. F4 This is the weighted average sales price representing 8,539 shares sold at prices ranging from $146.10 to $147.09 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  5. F5 This is the weighted average sales price representing 2,262 shares sold at prices ranging from $147.38 to $148.01 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
  6. F6 The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable.

More INSM filings

Not investment advice. Summaries can contain errors; the SEC filing is the official record.